- Home
- /
- Treatment
- /
- Page 64
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Bendamustine for 50ml admixture | Follicular lymphoma | Eagle Pharmaceuticals, Inc.;50 Tice Blvd, Suite 315;Woodcliff Lake, New Jersey, 07677 | July 2, 2014 | |
Bendamustine for 50 ml admixture | Chronic lymphocytic leukemia | Eagle Pharmaceuticals, INc.;50 Tice Blvd, Suite 315;Woodcliff Lake, New Jersey, 07677 | July 2, 2014 | |
Cannabidiol | Dravet Syndrome | Insys Development Company, Inc.;1333 S. Spectrum Blvd, Suite 100;Chandler, Arizona, 85286 | July 1, 2014 | |
2-(2-phenylvinyl)-4-[4-methylpiperazin-1-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt | Hepatocellular Carcinoma | CASI Pharmaceuticals, Inc.;9620 Medical Center Drive, Suite 300;Rockville, Maryland, 20850 | July 1, 2014 | |
Lumacaftor/ivacaftor | Cystic fibrosis | Vertex Pharmaceuticals Inc.;50 Northern Avenue;Boston, Massachusetts, 02210 | June 30, 2014 | |
Clofazimine | Active tuberculosis | Novartis Pharmaceuticals Corp.;One Health Plaza, Bldg 135/409;East Hanover, New Jersey, 07936 | June 25, 2014 | |
Cannabidiol | Lennox-Gastaut syndrome | Insys Development Company, Inc.;1333 S. Spectrum Blvd, Suite 100;Chandler, Arizona, 85286 | June 23, 2014 | |
(2’R,3’S)-2′-hydroxy-N-carboxy-3′-amino-5′-methyl-hexanoic,N-tert-butyl ester, 13 ester 5B-20-epoxy-1B,2a,4a,7B,9a,10a,13a-heptahydroxy-4,10-diacetate-2-benzoate-(1″S)-7,9-acrolein acetal-11(15-1)-abeotaxane | Progressive supranuclear palsy | Cortice Biosciences, Inc.;1345 Avenue of the Americas, 42nd Floor;New York, New York, 10105 | June 23, 2014 | |
Re188 P2045 somatostatin peptide analogue | Pancreatic cancer | Andarix Pharmaceuticals, Inc.;141 Powderhouse Blvd, Suite 1;Somerville, Massachusetts, 02144 | June 19, 2014 | |
Carglumic acid | Organic acidemias | Orphan Europe SARL;Immeuble Le Wilson, 70 avenue du General de Gaulle;92800 Puteaux | June 17, 2014 | |
6-[4-Deoxy-4-[(2E,4E)-tetradecadienoylglycyl]amino-L-glycero-B-L-manno-heptopyranosyl]amino-9H-purine | Multiple myeloma | DARA Therapeutics, Inc.;8601 Six Forks Road, Suite 160 (Forum 1);Raleigh, North Carolina, 27615 | June 12, 2014 | |
Epstein-Barr virus-specific autologous cytotoxic T lymphocytes | Epstein-Barr virus positive head and neck cancers (which includes nasopharyngeal carcinoma) | Tessa Therapeutics Pte.;8 Temasek Blvd #24-02, Suntec Tower Three; | June 12, 2014 | |
Mocetinostat | Myelodysplastic syndrome | Mirati Therapeutics, Inc.;9363 Towne Centre Drive, Suite 200;San Diego, California, 92121 | June 12, 2014 | |
Enasidenib | Acute myeloid leukemia | Celgene Corporation;Corporate Woods Bldg 32, Suite 900, 9225 Indian Creek Parkway;Overland Park, Kansas, 66210 | June 12, 2014 | |
Eculizumab | Myasthenia gravis Myasthenia gravis | Alexion Pharmaceuticals, Inc.;100 College Steet;New Haven, Connecticut, 06510 | June 12, 2014 | |
Autologous genetically modified human dermal fibroblasts | Dystrophic epidermolysis bullosa | Fibrocell Technologies, Inc.;405 Eagleview Blvd;Exton, Pennsylvania, 19341 | June 10, 2014 | |
(5R,5aR,8aR,9S)-9-[[4,6-O-[(R)-Ethylidene]-ß-D-glucopyranosyl]-oxy]-5-(4-({[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]carbonyl}oxy)-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydroisobenzofuro[5,6-f][1,3]benzodioxol-6(5aH)-one | Biliary tract cancer | Mundipharma Corporation Limited | June 4, 2014 | |
Afatinib | Malignant brain and central nervous system tumors | Boehringer Ingelheim Pharmaceuticals, Inc.;900 Ridgebury Road, P. O. Box 368;Ridgefield, Connecticut, 06877 | June 4, 2014 | |
Adeno-associated viral vector serotype 2 containing the humanCHMgene encoding human Rab escort protein 1 | Choroideremia | Alan Boyd Consultants Ltd | June 4, 2014 | |
(5R,5aR,8aR,9S)-9-[[4,6-O-[(R)-Ethylidene]-beta-D-glucopyranosyl]-oxy]-5-(4-({[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]carbonyl}oxy)-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydroisobenzofuro[5,6-f][1,3]benzodioxol-6(5aH)-one | Biliary tract cancer | Mundipharma Corporation Limited | June 4, 2014 | |
Adeno-associated viral vector serotype 2 containing the humanCHMgene encoding human Rab escort protein 1 | Choroideremia | Spark Therapeutics Ireland Ltd | June 4, 2014 | |
Everolimus | Diffuse large B-cell lymphoma | Novartis Pharmaceuticals Corp.;One Health Plaza;East Hanover, NJ, 07936-1080 | June 2, 2014 | |
Echothiophate iodide | Stargardt's disease | Makindus, Inc.;3805 Old Easton Road;Doylestown, Pennsylvania, 18902 | June 2, 2014 | |
Everolimus | Diffuse Large B-cell Lymphoma | Novartis Pharmaceuticals Corp.;One Health Plaza;East Hanover, New Jersey, 07936 | June 2, 2014 | |
2-[4-(1-Methyl-4-pyridin-4-yl-lH-pyrazol-3-yl)-phenoxymethyl]-quinoline succinic acid | Huntington disease | Pfizer Inc.;445 Eastern Point Road;Groton, Connecticut, 06340 | June 2, 2014 |